For the quarter ending 2026-03-31, BGLC has $9,040,130 in assets. $946,877 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and bank balances | 1,337,554 | 2,383,369 | 1,153,121 | 814,179 |
| Fixed deposits placed with financial institutions (including 1,566,985 and 1,553,322 of fixed deposits with original maturities more than 3 months as of march 31, 2026 and december 31, 2025 respectively) | 2,627,408 | 1,656,336 | 1,741,532 | 2,244,699 |
| Trade receivables, net of allowance for credit losses of 878,903 and 703,995 as of march 31, 2026 and december 31, 2025 respectively (including nil and 31,420 of trade receivables from related party as of march 31, 2026 and december 31, 2025 respectively) | 79,860 | 505,885 | 1,522,158 | 1,852,085 |
| Other receivables, deposits and prepayments | 88,983 | 81,728 | 98,903 | 151,269 |
| Other assets | 333,332 | 83,333 | - | - |
| Tax recoverable | 61,611 | 61,384 | 103,640 | 101,471 |
| Inventories | 667,154 | 676,703 | 1,007,448 | 1,215,623 |
| Total current assets | 5,195,902 | 5,448,738 | 5,626,802 | 6,379,326 |
| Operating lease right-of-use assets | 163,113 | 177,737 | 186,082 | 200,284 |
| Finance lease right-of-use assets | 75,383 | - | - | - |
| Property, plant and equipment, net | 1,577,279 | 1,598,769 | 1,570,584 | 1,592,907 |
| Investments in equity securities | 2,028,453 | 2,027,540 | 237,760 | 1,248,688 |
| Total non-current assets | 3,844,228 | 3,804,046 | 1,994,426 | 3,041,879 |
| Total assets | 9,040,130 | 9,252,784 | 7,621,228 | 9,421,205 |
| Trade payables | 2,137 | 2,335 | 184,600 | 1,367,535 |
| Other payables and accrued liabilities (including 233,332 and 83,333 of other payables from related party as of march 31, 2026 and december 31, 2025 respectively) | 589,700 | 401,611 | 375,380 | 307,340 |
| Current portion of operating lease liabilities | 58,251 | 59,147 | 56,803 | 55,809 |
| Current portion of obligation under finance lease | 7,770 | - | - | - |
| Advance payment from customer | 8,416 | 8,385 | 11,264 | 11,348 |
| Amount owing to directors | 130,196 | 49,479 | 49,976 | 15,789 |
| Total current liabilities | 796,470 | 520,957 | 678,023 | 1,757,821 |
| Non-current portion of operating lease liabilities | 103,802 | 116,899 | 126,943 | 141,347 |
| Deferred tax liabilities | - | - | 0 | 0 |
| Non-current portion of obligation under finance lease | 46,605 | - | - | - |
| Total non-current liability | 150,407 | 116,899 | 126,943 | 141,347 |
| Total liabilities | 946,877 | 637,856 | 804,966 | 1,899,168 |
| As at march 31, 2026, common stock, no par value 300,000,000 shares authorized and 2,417,314 shares outstanding, and preferred stock, no par value 30,000,000 shares authorized and no shares outstanding. as at december 31, 2025, common stock, no par value 300,000,000 shares authorized and 2,417,314 shares outstanding, and preferred stock, no par value 30,000,000 share authorized and no shares outstanding (on a post-reverse stock split basis) | 20,174,795 | 20,174,795 | 17,331,810 | 17,331,810 |
| Additional paid in capital | -5,011,891 | -5,011,891 | -5,011,891 | -5,011,891 |
| Accumulated deficit | -6,970,802 | -6,427,227 | -5,391,110 | -4,682,119 |
| Accumulated other comprehensive losses | -98,849 | -120,749 | -112,547 | -115,763 |
| Total stockholders' equity | 8,093,253 | 8,614,928 | 6,816,262 | 7,522,037 |
| Total liabilities and stockholders' equity | 9,040,130 | 9,252,784 | 7,621,228 | 9,421,205 |
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp (BGLC)